Cemiplimab for advanced non-small cell lung cancer: Squamous subgroup analysis for EMPOWER-Lung 1 and 3

dc.authoridBondarenko, Igor/0000-0002-7071-2471
dc.authorwosidBondarenko, Igor/U-5156-2017
dc.contributor.authorMakharadze, T.
dc.contributor.authorGogishvili, M.
dc.contributor.authorMelkadze, T.
dc.contributor.authorBaramidze, A.
dc.contributor.authorSezer, A.
dc.contributor.authorKilickap, S.
dc.contributor.authorGumus, M.
dc.date.accessioned2024-05-19T14:50:28Z
dc.date.available2024-05-19T14:50:28Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- OCT 20-24, 2023 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.description.sponsorshipRegeneron Pharmaceuticals, Inc.; Sanofien_US
dc.description.sponsorshipRegeneron Pharmaceuticals, Inc., and Sanofi.en_US
dc.identifier.doi10.1016/j.annonc.2023.09.2469
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://doi.org10.1016/j.annonc.2023.09.2469
dc.identifier.urihttps://hdl.handle.net/20.500.12713/5719
dc.identifier.volume34en_US
dc.identifier.wosWOS:001087480202114en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240519_kaen_US
dc.subject[No Keywords]en_US
dc.titleCemiplimab for advanced non-small cell lung cancer: Squamous subgroup analysis for EMPOWER-Lung 1 and 3en_US
dc.typeConference Objecten_US

Dosyalar